Last reviewed · How we verify

D-Col Personal Hygiene Convenience Kit (col)

Pfizer · FDA-approved approved Quality 37/100

COL's mechanism of action is not well-documented, but it is believed to target various molecular targets.

D-Col Personal Hygiene Convenience Kit, manufactured by Pfizer, holds a unique market position as a personal hygiene product with three approved indications, though its exact mechanism of action remains unclear. Despite the lack of clinical trial data, its broad approval base provides a competitive edge over targeted therapies like Otezla and Adalimumab, which have specific indications. A key risk lies in the requirement for a PD-L1 companion diagnostic for several of its indications, potentially limiting its market reach. The pipeline outlook is uncertain due to the absence of ongoing clinical trials, raising questions about future growth and innovation.

At a glance

Generic namecol
SponsorPfizer
Drug classnot well-documented
Targetvarious molecular targets
Therapeutic areaDermatology
PhaseFDA-approved

Mechanism of action

COL's mechanism of action is not well-documented, but it is believed to target various molecular targets. The exact molecular targets of COL are not publicly available. Further research is needed to fully understand COL's pharmacological class and modality.

Approved indications

Common side effects

No common side effects on file.

Drug interactions